The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
NEW ISSUE
The ISCHEMIA trial in real-world practice, a new “uncaging” coronary stent, PCI of the LM trifurcation in the EXCEL trial and more...
December 18, 2020
NEW
Elective Cardiac Invasive Procedures during the COVID-19 Outbreak
A. Chieffo et al.
January 8, 2021
Editorial
Addressing interventional periprocedural anxiety with virtual reality
Nico Bruining
January 13, 2021
Trials Book
SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS
(Thanks to the support of Biotronik)
January 13, 2021
Guidance Papers
Guidelines, consensus & position papers
August 28, 2020
Editorial
Translating ISCHEMIA into practice
William E. Boden
January 13, 2021
JAA
This Week's JAA's: BIOFREEDOM-QCA trial, TTVr with the TriClip/MitraClip G4 System, Numerical prediction of coronary artery compression in TPVI...
January 12, 2021

The editor's choice

Valvular disease
Virtual reality-assisted conscious sedation during transcatheter aortic valve implantation: a randomised pilot study
Raphael Bruno
Bruno R et al
December 18, 2020
10.4244/EIJ-D-20-00269
Valvular disease
A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation
Nicola Buzzatti
Buzzatti N et al
December 18, 2020
10.4244/EIJ-D-20-00475
Coronary
Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system
Stefan Verheye
Verheye S et al
December 18, 2020
10.4244/EIJ-D-20-00763
Coronary
External applicability of the ISCHEMIA trial: an analysis of a prospective, nationwide registry of patients with stable coronary artery disease
Leonardo De Luca
De Luca L et al
December 18, 2020
10.4244/EIJ-D-20-00610

Latest articles

Interventions for valvular disease
Transcatheter Tricuspid Valve Repair with the Modified TriClip/MitraClip G4 System
Fam N, Ali FM, Hassanin M, Ong G
January 12, 2021 | 10.4244/EIJ-D-20-01295
Coronary interventions
Efficacy of Thin- Versus Thick-Strut Polymer-Free Biolimus-Eluting Stents: the Biofreedom QCA Randomized Trial
Sabaté M, Okkels-Jensen L, Tilsted H, Moreno R, García del Blanco B, Macaya C, Perez de Prado A, Cequier A, Pérez-Fuentes P, Schütte D, Costa R, Stoll H, Lassen J
January 12, 2021 | 10.4244/EIJ-D-20-01162
Interventions for valvular disease
Computer-based prediction of coronary artery compression in the planning of transcatheter pulmonary valve implantation.
Pluchinotta FR, Caimi A, Pilati M, Carminati M, Sturla F
January 12, 2021 | 10.4244/EIJ-D-20-01114
Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Chieffo A, Tarantini G, Naber C, Barbato E, Roffi M, Stefanini G, Buchanan G, Buszman P, Moreno R, Zawiślak B, Cayla G, Danenberg H, Da Silveira J, Nef H, James S, Mauri Ferre J, Voskuil M, Witt N, Windecker S, Baumbach A, Dudek D
January 8, 2021 | 10.4244/EIJ-D-20-01291
Interventions for valvular disease
Transcatheter Aortic Valve Neo-Commissure Alignment with the Portico System
Tagliari AP, Vicentini L, Zimmermann JM, Miura M, Ferrari E, Perez D, Haager PK, Jörg L, Maisano F, Taramasso M
December 22, 2020 | 10.4244/EIJ-D-20-01095
Peripheral interventions
Long-Term Safety of Drug-Coated Devices for Peripheral Revascularisation
Secemsky EA, Barrette E, Bockstedt L, Bonaca M, Hess CN, Hanson T, Monteiro J, Manda B, Yeh R
December 22, 2020 | 10.4244/EIJ-D-20-01018
Coronary interventions
Prognostic Impact and Clinical Outcomes of Coronary Flow Reserve and Hyperemic Microvascular Resistance
Toya T, Corban M, Park JY, Ahmad A, Ozcan I, Sebaali F, Sara J, Gulati R, Lerman L, Lerman A
December 22, 2020 | 10.4244/EIJ-D-20-00853
Applicability of the ISCHEMIA trial in real-world practice, a new “uncaging” coronary stent, PCI of the left main trifurcation in the EXCEL trial, coronary re-access after TAVI, virtual reality and conscious sedation, renal flow reserve, and more…
Capodanno D
December 18, 2020
Translating the findings of ISCHEMIA into clinical practice: a challenging START
Boden W, Bhatt D
December 18, 2020 | 10.4244/EIJV16I12A174
"Uncaging" the artery with a novel metallic coronary device
Kimura T, Yamamoto K
December 18, 2020 | 10.4244/EIJV16I12A175
Coronary re-access after redo TAVI: a proposed classification to simplify evaluation
Tang G, Zaid S
December 18, 2020 | 10.4244/EIJV16I12A176
Addressing interventional periprocedural anxiety with virtual reality
Bruining N, Cummins P, de Jaegere P
December 18, 2020 | 10.4244/EIJV16I12A177
External applicability of the ISCHEMIA trial: an analysis of a prospective, nationwide registry of patients with stable coronary artery disease
De Luca L, Uguccioni M, Meessen J, Temporelli P, Tomai F, De Rosa F, Passamonti E, Formigli D, Riccio C, Gabrielli D, Colivicchi F, Gulizia M, Perna G
December 18, 2020 | 10.4244/EIJ-D-20-00610
Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system
Verheye S, Vrolix M, Montorfano M, Zivelonghi C, Giannini F, Bedogni F, Dubois C, De Bruyne B, Costa R, Chamié D, de Ribamar Costa J, Kereiakes D, Abizaid A, Colombo A
December 18, 2020 | 10.4244/EIJ-D-20-00763
Procedural characteristics and clinical outcomes in patients undergoing percutaneous coronary intervention for left main trifurcation disease: the EXCEL trial
Kandzari D, Gershlick A, Serruys P, Leon M, Morice M, Simonton C, Lembo N, Mansour S, Sabaté M, Sabik J, Kappetein A, Dressler O, Stone G
December 18, 2020 | 10.4244/EIJ-D-19-00686
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke